Medicare Enrolled

Dr. George Kariampuzha, MD

Neurology · Tyler, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
910 E HOUSTON ST, Tyler, TX 75702
9035108848
In practice since 2006 (20 years)
NPI: 1235103201 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kariampuzha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kariampuzha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kariampuzha

Dr. George Kariampuzha is a neurology in Tyler, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kariampuzha performed 1,792 Medicare services across 1,175 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kariampuzha received a total of $39,125 from 37 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kariampuzha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 20% volume in TX$ $39,125 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,792
Medicare services
Top 20% in TX for neurology
1,175
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~90 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)340$104$406
Needle measurement of electrical activity in arm or leg muscles, complete study318$35$228
Office visit, established patient (30-39 min)193$68$289
Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)162$25$72
New patient office visit, complex (60-74 min)120$136$496
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box104$108$458
Office visit, established patient (20-29 min)99$47$204
Nerve conduction, 13 or more studies81$142$664
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional72$152$470
Hospital follow-up visit, low complexity43$38$86
Injection of trigger points, 3 or more muscles32$23$210
Critical care, first 30-74 min31$165$624
Needle measurement of electrical activity in arm or leg muscles, 2 extremities29$63$569
Initial hospital admission, high complexity25$125$441
Measurement of brain wave activity (eeg), awake and drowsy23$41$863
Placement of skin electrodes and measurement of stimulated sites on arms and legs22$35$820
New patient office visit (30-44 min)20$64$251
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve17$47$329
Nerve conduction, 9-10 studies17$101$492
Hospital follow-up visit, moderate complexity16$62$159
Hospital discharge day management, 30 minutes or less16$63$160
Initial hospital admission, moderate complexity12$93$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$39,125
Total received (2018-2024)
Avg $5,589/year across 7 years
Top 11% in TX for neurology
37
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34,581 (88.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,544 (11.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,070
2023
$6,734
2022
$6,542
2021
$9,026
2020
$8,465
2019
$1,511
2018
$776

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$17,683
Allergan, Inc.
$10,086
AbbVie Inc.
$6,786
Amgen Inc.
$749
Neurocrine Biosciences, Inc.
$733
Biogen, Inc.
$345
UCB, Inc.
$314
Biohaven Pharmaceuticals, Inc.
$245
Teva Pharmaceuticals USA, Inc.
$242
Genentech USA, Inc.
$175
Lilly USA, LLC
$169
Lundbeck LLC
$156
Avanir Pharmaceuticals, Inc.
$136
SK Life Science, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$117
MDD US Operations, LLC
$116
Otsuka Pharmaceutical Development & Commercialization, Inc.
$112
JAZZ PHARMACEUTICALS INC.
$109
Allergan Inc.
$105
ACADIA Pharmaceuticals Inc
$104
HARMONY BIOSCIENCES LLC
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
LivaNova USA, Inc.
$42
EMD Serono, Inc.
$33
Supernus Pharmaceuticals, Inc.
$31
Pharming Healthcare, Inc.
$26
Novartis Pharmaceuticals Corporation
$25
AbbVie, Inc.
$24
GENZYME CORPORATION
$21
Greenwich Biosciences, Inc.
$19
CSL Behring
$19
Kedrion Biopharma Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
US WorldMeds, LLC
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
PFIZER INC.
$14
BOSTON SCIENTIFIC CORPORATION
$14
Top 3 companies account for 88.3% of total payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · APOKYN · AUBAGIO · AUSTEDO · Actemra · Aimovig · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · Duopa · EMGALITY · Epidiolex · GENERAL DBS · Gammaked · Gocovri · HYQVIA · Hizentra · INGREZZA · JARDIANCE · MAYZENT · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · QULIPTA · Repatha · SOLIRIS · SUNOSI · TECFIDERA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · UPLIZNA · VNS Therapy · Wakix · XCOPRI · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $2,183 per 100 Medicare services performed
Looking for a neurology in Tyler?
Compare neurologys in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
24
Per 100K population
10.1
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kariampuzha is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), and high industry engagement (speaking/promotional, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kariampuzha experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Kariampuzha performed 340 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kariampuzha receive payments from pharmaceutical companies?
Yes. Dr. Kariampuzha received a total of $39,125 from 37 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kariampuzha's costs compare to other neurologys in Tyler?
Dr. Kariampuzha's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kariampuzha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →